Medical conditions or treatments at the time of the blood clot formation included obesity in 22 (63%) subjects, 8 (23%) who had diabetes, and 5 (14%) who received growth hormone treatment. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.